Random Integration vs. Semi-Targeted Integration In Stable Cell Line Development

Trying to decide what integration method is best for your cell line development (CLD) program? Comparing random integration with semi-targeted (i.e. Transposase) integration side by side, this whitepaper demonstrates that clones developed using random integration often result in higher expression levels, improved growth characteristics, and superior process robustness compared to semi-targeted systems. While semi-targeted approaches may offer precision, they may fall short in overall efficiency and productivity — especially in late-stage manufacturing.
If you're selecting an integration method for your CLD program, download this whitepaper today to access data-backed insights to inform a more confident, future-proofed decision.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.